AVI GOLDIN, the CFO of $GNE, sold 12,000 shares of the company on 11-18-2025 for an estimated $175,354. We received data on the trade from a recent SEC filing. This was a sale of approximately 11.1% of their shares of this class of stock. Following this trade, they now own 96,491 shares of this class of $GNE stock.
$GNE Insider Trading Activity
$GNE insiders have traded $GNE stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $GNE stock by insiders over the last 6 months:
- AVI GOLDIN (CFO) sold 12,000 shares for an estimated $175,354
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$GNE Hedge Fund Activity
We have seen 58 institutional investors add shares of $GNE stock to their portfolio, and 70 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JACOBS LEVY EQUITY MANAGEMENT, INC added 304,062 shares (+inf%) to their portfolio in Q3 2025, for an estimated $4,545,726
- BLACKROCK, INC. removed 260,169 shares (-10.6%) from their portfolio in Q3 2025, for an estimated $3,889,526
- J. GOLDMAN & CO LP added 189,300 shares (+inf%) to their portfolio in Q3 2025, for an estimated $2,830,035
- NUVEEN, LLC removed 95,966 shares (-62.1%) from their portfolio in Q3 2025, for an estimated $1,434,691
- VICTORY CAPITAL MANAGEMENT INC added 95,370 shares (+1040.2%) to their portfolio in Q3 2025, for an estimated $1,425,781
- MORGAN STANLEY removed 83,603 shares (-42.7%) from their portfolio in Q3 2025, for an estimated $1,249,864
- QUBE RESEARCH & TECHNOLOGIES LTD removed 78,586 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $2,112,391
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
